Dantrolene, A Treatment for Alzheimer Disease?
Authors:
- 1 January 2015
- journal article
- review article
- Published by Wolters Kluwer Health in Alzheimer Disease & Associated Disorders
- Vol. 29 (1) , 1-5
Abstract
Alzheimer disease (AD) is a fatal progressive disease and the most common form of dementia without effective treatments. Previous studies support that the disruption of endoplasmic reticulum Ca2+ through overactivation of ryanodine receptors plays an important role in the pathogenesis of AD. Normalization of intracellular Ca2+ homeostasis could be an effective strategy for AD therapies. Dantrolene, an antagonist of ryanodine receptors and an FDA-approved drug for clinical treatment of malignant hyperthermia and muscle spasms, exhibits neuroprotective effects in multiple models of neurodegenerative disorders. Recent preclinical studies consistently support the therapeutic effects of dantrolene in various types of AD animal models and were summarized in the current review.Keywords
This publication has 109 references indexed in Scilit:
- Altered ryanodine receptor expression in mild cognitive impairment and Alzheimer's diseaseNeurobiology of Aging, 2012
- Dantrolene ameliorates cognitive decline and neuropathology in Alzheimer triple transgenic miceNeuroscience Letters, 2012
- Protein Homeostasis, Aging and Alzheimer’s DiseaseMolecular Neurobiology, 2012
- Calcium channel blocking as a therapeutic strategy for Alzheimer's disease: The case for isradipineBiochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, 2011
- Presenilins function in ER calcium leak and Alzheimer's disease pathogenesisCell Calcium, 2011
- Cyclophilin D deficiency improves mitochondrial function and learning/memory in aging Alzheimer disease mouse modelNeurobiology of Aging, 2011
- A Prochelator Activated by β-Secretase Inhibits Aβ Aggregation and Suppresses Copper-Induced Reactive Oxygen Species FormationJournal of the American Chemical Society, 2010
- The dysregulation of intracellular calcium in Alzheimer diseaseCell Calcium, 2010
- Evidence supporting a role for the calcium‐sensing receptor in Alzheimer diseaseAmerican Journal of Medical Genetics Part B: Neuropsychiatric Genetics, 2009
- Reassessing the amyloid cascade hypothesis of Alzheimer's diseaseThe International Journal of Biochemistry & Cell Biology, 2009